{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:32:10Z","timestamp":1755217930669,"version":"3.43.0"},"reference-count":28,"publisher":"Georg Thieme Verlag KG","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1055\/a-2498-1456","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:40:46Z","timestamp":1754433646000},"page":"937-944","source":"Crossref","is-referenced-by-count":0,"title":["Aktuelle Leitlinien zum Vorhofflimmern"],"prefix":"10.1055","volume":"150","author":[{"given":"Julian","family":"Wolfes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"issue":"36","key":"ref1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"IC Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"E Svennberg","year":"2021","journal-title":"Lancet"},{"issue":"21","key":"ref4","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.jacc.2024.08.019","article-title":"Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention","volume":"84","author":"RD Lopes","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"ref5","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.124.071176","article-title":"Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year Olds to Detect Atrial Fibrillation \u2013 STROKESTOP II","volume":"150","author":"K Kemp Gudmundsdottir","year":"2024","journal-title":"Circulation"},{"issue":"01","key":"ref6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/europace\/euac144","article-title":"Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper","volume":"25","author":"Z Kalarus","year":"2023","journal-title":"Europace"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol Abstinence in Drinkers with Atrial Fibrillation","volume":"382","author":"A Voskoboinik","year":"2020","journal-title":"N Engl J Med"},{"issue":"14","key":"ref8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality","volume":"389","author":"C Global Cardiovascular Risk","year":"2023","journal-title":"N Engl J Med"},{"issue":"02","key":"ref9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/2047487318811184","article-title":"Depression, antidepressants, and the risk of non-valvular atrial fibrillation: A nationwide Danish matched cohort study","volume":"26","author":"M Fenger-Gron","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"36","key":"ref10","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1093\/eurheartj\/ehae539","article-title":"Gender and contemporary risk of adverse events in atrial fibrillation","volume":"45","author":"A Champsi","year":"2024","journal-title":"Eur Heart J"},{"issue":"13","key":"ref11","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes","volume":"389","author":"P Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"issue":"02","key":"ref12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation","volume":"390","author":"JS Healey","year":"2024","journal-title":"N Engl J Med"},{"issue":"01","key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2024.04.001","article-title":"Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation","volume":"35","author":"FK Wegner","year":"2024","journal-title":"Trends Cardiovasc Med"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s12913-019-4372-y","article-title":"Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices \u2013 results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment)","volume":"19","author":"C Mertens","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1160\/TH17-10-0733","article-title":"Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61000 Patients with Atrial Fibrillation","volume":"118","author":"SH Hohnloser","year":"2018","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref16","first-page":"279","article-title":"Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial","volume":"149","author":"LPT Joosten","year":"2024","journal-title":"Circulation"},{"issue":"22","key":"ref17","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke","volume":"384","author":"RP Whitlock","year":"2021","journal-title":"N Engl J Med"},{"issue":"13","key":"ref18","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left Atrial Appendage Closure after Ablation for Atrial Fibrillation","volume":"392","author":"OM Wazni","year":"2025","journal-title":"N Engl J Med"},{"issue":"14","key":"ref19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early Rhythm-Control Therapy in Patients with Atrial Fibrillation","volume":"383","author":"P Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"issue":"40","key":"ref20","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1093\/eurheartj\/ehac471","article-title":"Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial","volume":"43","author":"L Eckardt","year":"2022","journal-title":"Eur Heart J"},{"issue":"02","key":"ref21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of Atrial Fibrillation after Cryoablation or Drug Therapy","volume":"388","author":"JG Andrade","year":"2023","journal-title":"N Engl J Med"},{"issue":"04","key":"ref22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jacep.2024.12.018","article-title":"Comparison of the Latest ESC, ACC\/AHA\/ACCP\/HRS, and CCS Guidelines on the Management of Atrial Fibrillation","volume":"11","author":"J Wolfes","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"issue":"05","key":"ref23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.tcm.2023.04.001","article-title":"Benefits of early rhythm control of atrial fibrillation","volume":"34","author":"L Eckardt","year":"2024","journal-title":"Trends Cardiovasc Med"},{"issue":"07","key":"ref24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2012.11.038","article-title":"Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation)","volume":"61","author":"HF Groenveld","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"ref25","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1001\/jama.2020.23138","article-title":"Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial","volume":"324","author":"D Kotecha","year":"2020","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"h4937","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data","volume":"351","year":"2015","journal-title":"BMJ"},{"issue":"46","key":"ref27","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1093\/eurheartj\/ehab569","article-title":"AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial","volume":"42","author":"M Brignole","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"ref28","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1016\/j.cjca.2024.07.021","article-title":"Pulmonary Vein Isolation or Pace and Ablate in Elderly Patients With Persistent Atrial Fibrillation (ABLATE Versus PACE)-Rationale, Methods, and Design","volume":"40","author":"AA Boehmer","year":"2024","journal-title":"Can J Cardiol"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00392-018-1368-2","article-title":"Long-term symptom improvement and patient satisfaction after AV-node ablation vs. pulmonary vein isolation for symptomatic atrial fibrillation: results from the German Ablation Registry","volume":"108","author":"K Wasmer","year":"2019","journal-title":"Clin Res Cardiol"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2498-1456.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:40:51Z","timestamp":1754433651000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2498-1456"}},"subtitle":["Was empfehlen AWMF und ESC?"],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":28,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8,5]]},"published-print":{"date-parts":[[2025,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2498-1456","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"type":"print","value":"0012-0472"},{"type":"electronic","value":"1439-4413"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}